Allergan (AGN) Misses Q4 EPS by 1c, Sales Beat; Guides Q1, FY11
Tweet Send to a Friend
Allergan Inc. (NYSE: AGN) reported Q4 EPS of $0.88, ex-items, $0.01 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
